A new editorial publication states that Keratinocyte (skin) cancer is the most common form of human cancer, yet limited treatment advances have been made in the past 10 years and few quality clinical trials have been published, particularly from Australia.

A melanoma clinical trial with a site in Carlton, Victoria, will examine the effectiveness of Melanoma Surveillance Photography – offering state-of-the-art technology aiming to improve surveillance for people at high risk of melanoma.

A world-wide clinical trial is now hoping to resolve this issue by investigating whether there is a difference in disease-free survival for patients treated with either a 1cm or 2cm excision margin for stage II primary cutaneous melanoma.

New melanoma research has shown the concurrent use of two drugs that slow the growth of metastatic melanoma, Dabrafenib and Trametinib, are safe to use during palliative radiation therapy.

A drug commonly used to treat prostate and breast cancer is being trialled in Bendigo to determine its effectiveness in treating melanoma, and more Bendigo residents with melanoma are being sought for the study.

A new melanoma clinical trial involving Bass Coast residents aims to improve surveillance for people at high risk of melanoma.

New virtual melanoma nurse, an Australian-first for regional and rural Australians

The AOMA-funded virtual melanoma nurse is a new specialist telehealth service to support patients with ocular melanoma in remote and regional areas of Australia.

Professor H. Peter Soyer, Director of The University of Queensland Diamantina Institute, with melanoma screening system, VECTRA

Professor H. Peter Soyer is focused on improving the early detection of skin cancer through a nationwide melanoma screening program.

Uveal Melanoma Registry launched in Australia

MASC Trials opens the Australian arm of the first global patient registry for uveal melanoma.

IMAT Clinical Trial

Join Dr Wen Xu, Prof. Gerald Fogarty and Jonathan Pincus for a discussion about the I-MAT clinical trial, which aims to improve the management of early stage Merkel Cell Carcinoma.